Poulomi Das

If there was an award for turning inventive premises into a drag-fest, I’m certain Indian storytellers would be contending for it. In the last decade of Indian streaming, there has been nothing more frustrating than witnessing filmmakers self-sabotage projects that could have otherwise become definitive storytelling. It’s worse than having to sit through shows that resemble a template and underwhelm in their lack of ambition and finesse. Such shows are easy to churn and easier to forget, their existence devoid of any purpose beyond existing for the sake of populating a catalogue.

In this post-Covid world, the timing of Pill – an eight-episode examination of the malpractices of Big Indian Pharma that end up endangering human lives — could not be more timely. Just a few months ago, AstraZeneca, the British-Swedish pharmaceutical company, admitted that Covishield, its Covid vaccine, can cause side-effects such as blood clots, low platelet counts, and neurological deficits. If that’s not worrying enough, AstraZeneca is already facing a class action lawsuit in the UK that accuses its vaccine of causing deaths. So far, 51 cases have been filed against the multinational giant. That is to say, for a country that has survived the pandemic and come out on the other side only to discover the long-term side-effects of the vaccines on our bodies, such a show exists as cinematic retribution.

Raj Acharya’s “Murder in Mahim” – the eight-episode police procedural streaming on JioCinema, suffers from an adaptation problem, the most unfortunate flaw currently ailing Indian long-format storytelling. The story, about the violent murders of lower-class sex workers, is adapted from Jerry Pinto’s eponymous novel and the show is helmed by Vijay Raaz and Ashutosh Rana, two formidable acting powerhouses capable of elevating any script.